Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings
- PMID:27128862
- DOI: 10.1097/FBP.0000000000000241
Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings
Abstract
An increasing number of novel psychoactive substances are currently available and sold as 'legal highs' or 'research chemicals' accompanied by the indication that they are 'not for human consumption'. Among those that have emerged in the last few years, methoxetamine (MXE) owes its wide popularity to its easy access on the Internet and its reputation of being a 'safe' drug. MXE is an arylcyclohexylamine with a chemical structure analogous to ketamine and phencyclidine, and similar noncompetitive glutamate N-methyl D-aspartate receptor antagonist properties. Yet, very recent preclinical data highlighted a stimulatory effect of MXE on dopamine neurotransmission within the mesolimbic pathway. The aim of this review is to provide an updated review of the behavioral and toxicological effects of MXE as well as the latest findings on its pharmacology that might explain sought effects and frequent occurrence of adverse effects. In light of the growing number of intoxications induced by MXE, knowledge of its short-term and long-term effects is urgently needed. However, the hypothetical rapid antidepressant activity of MXE suggested by its chemical analogy with ketamine and supported by recent preclinical findings deserves further investigation.
Similar articles
- Methoxetamine: A foe or friend?Botanas CJ, de la Peña JB, Kim HJ, Lee YS, Cheong JH.Botanas CJ, et al.Neurochem Int. 2019 Jan;122:1-7. doi: 10.1016/j.neuint.2018.10.020. Epub 2018 Oct 24.Neurochem Int. 2019.PMID:30365979Review.
- Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine.Corazza O, Schifano F, Simonato P, Fergus S, Assi S, Stair J, Corkery J, Trincas G, Deluca P, Davey Z, Blaszko U, Demetrovics Z, Moskalewicz J, Enea A, di Melchiorre G, Mervo B, di Furia L, Farre M, Flesland L, Pasinetti M, Pezzolesi C, Pisarska A, Shapiro H, Siemann H, Skutle A, Enea A, di Melchiorre G, Sferrazza E, Torrens M, van der Kreeft P, Zummo D, Scherbaum N.Corazza O, et al.Hum Psychopharmacol. 2012 Mar;27(2):145-9. doi: 10.1002/hup.1242.Hum Psychopharmacol. 2012.PMID:22389078Review.
- Methoxetamine--a novel recreational drug with potent hallucinogenic properties.Zawilska JB.Zawilska JB.Toxicol Lett. 2014 Nov 4;230(3):402-7. doi: 10.1016/j.toxlet.2014.08.011. Epub 2014 Aug 13.Toxicol Lett. 2014.PMID:25128700Review.
- R (-)-methoxetamine exerts rapid and sustained antidepressant effects and fewer behavioral side effects relative to S (+)-methoxetamine.Botanas CJ, Perez Custodio RJ, Kim HJ, de la Pena JB, Sayson LV, Ortiz DM, Kim M, Lee HJ, Acharya S, Kim KM, Lee CJ, Ryu JH, Lee YS, Cheong JH.Botanas CJ, et al.Neuropharmacology. 2021 Aug 1;193:108619. doi: 10.1016/j.neuropharm.2021.108619. Epub 2021 May 20.Neuropharmacology. 2021.PMID:34023336
- Phencyclidine-like in vivo effects of methoxetamine in mice and rats.Berquist MD, Hyatt WS, Bauer-Erickson J, Gannon BM, Norwood AP, Fantegrossi WE.Berquist MD, et al.Neuropharmacology. 2018 May 15;134(Pt A):158-166. doi: 10.1016/j.neuropharm.2017.08.028. Epub 2017 Aug 19.Neuropharmacology. 2018.PMID:28830759Free PMC article.
Cited by
- Effects of N-Methyl-D-aspartate (NMDA) antagonists ketamine, methoxetamine, and phencyclidine on the odor span test of working memory in rats.Mathews MJ, Mead RN, Galizio M.Mathews MJ, et al.Exp Clin Psychopharmacol. 2018 Feb;26(1):6-17. doi: 10.1037/pha0000158.Exp Clin Psychopharmacol. 2018.PMID:29389166Free PMC article.
- Effects of the Phenethylamine 2-Cl-4,5-MDMA and the Synthetic Cathinone 3,4-MDPHP in Adolescent Rats: Focus on Sex Differences.Pisanu A, Lo Russo G, Talani G, Bratzu J, Siddi C, Sanna F, Diana M, Porcu P, De Luca MA, Fattore L.Pisanu A, et al.Biomedicines. 2022 Sep 20;10(10):2336. doi: 10.3390/biomedicines10102336.Biomedicines. 2022.PMID:36289598Free PMC article.
- Sex and Gender Differences in the Effects of Novel Psychoactive Substances.Fattore L, Marti M, Mostallino R, Castelli MP.Fattore L, et al.Brain Sci. 2020 Sep 3;10(9):606. doi: 10.3390/brainsci10090606.Brain Sci. 2020.PMID:32899299Free PMC article.Review.
- Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications.Giorgetti A, Pascali JP, Fais P, Pelletti G, Gabbin A, Franchetti G, Cecchetto G, Viel G.Giorgetti A, et al.Life (Basel). 2021 May 14;11(5):440. doi: 10.3390/life11050440.Life (Basel). 2021.PMID:34068903Free PMC article.Review.
- Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies.Costa G, De Luca MA, Piras G, Marongiu J, Fattore L, Simola N.Costa G, et al.Neural Regen Res. 2020 May;15(5):802-816. doi: 10.4103/1673-5374.268895.Neural Regen Res. 2020.PMID:31719240Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical